Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, discusses the possibility of the use of sputum analysis for lung cancer screening. References…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, shares his thoughts on the cost of lung cancer screening. Sponsored by The Doctor’s…
For patients on continuous medication for pain relief in late-stage illness, the FDA has approved methylnaltrexone bromide (Relistor) injection for treatment of opioid-induced constipation. References and Resources FDA…
According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, Washington, discusses the Center for Advanced Brain Tumor Treatment. For more information visit: Center…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer. References and Resources Schönekaes K, Mücke R,…
A feasibility study presented at the American Association for Cancer Research meeting showed that intraductal chemotherapy may have potential as a treatment for ductal carcinoma in situ and…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses lung cancer in…
A study presented at the American Association for Cancer Research meeting showed progression of androgen-independent prostate cancer was significantly inhibited in mice by a combination of atorvastatin (Lipitor)…
